_id

690db5feccc777a4e85d0df9

Ticker

BCRX

Name

BioCryst Pharmaceuticals Inc

Exchange

NASDAQ

Address

4505 Emperor Boulevard, Durham, NC, United States, 27703

Country

USA

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Currency

USD

Website

https://www.biocryst.com

Description

BioCryst Pharmaceuticals, Inc., a biotechnology company, develops oral small-molecule and injectable protein therapeutics to treat rare diseases. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat hereditary angioedema. It is also developing BCX17725, a protein therapeutic for netherton syndrome which is in phase 1; Avoralstat, an ocular plasma kallikrein inhibitor for diabetic macular edema that is in preclinical phase; and BCX10013, an oral Factor D inhibitor for complement-mediated diseases, as well as developing Oral C5 Inhibitor and Oral C2 Inhibitor. The company has collaborations and in-license relationships with the Torii Pharmaceutical Co., Shionogi & Co., Ltd., Green Cross Corporation; National Institute of Allergy and Infectious Diseases; Biomedical Advanced Research and Development Authority; the U.S. Department of Health and Human Services; and The University of Alabama at Birmingham, as well as Albert Einstein College of Medicine of Yeshiva University and Industrial Research, Ltd. BioCryst Pharmaceuticals, Inc. was founded in 1986 and is headquartered in Durham, North Carolina.

Last Close

7.58

Volume

3731150

Current Price

7.57

Change

-0.13192612137202883

Last Updated

2025-11-28T12:46:25.485Z

Image

data:image/webp;base64,UklGRlABAABXRUJQVlA4IEQBAABQCQCdASpAAEAAPrVSoEunJSMhqBv8qOAWiWUAziwZz3kAA3/tcxIC7SZqG5cFu3RtsuVzkeoi6a+oloqXc/qE3WU8eDBI0iLnuFi8Z3Rh51iqAAD+91kv3ZTQiVH69G99SIkb7OQXMSH85/kf5lKzFMsQmLbVuSbcnbOBDbS22bNmMZLjdi7If4xw3HjRWGFBmI0qXNb9DWmpzPoC0PGGkaAlXRDE8xBTZKNeqa/J/Wp5E1ZAVkt++yjHW8IdIip4MRkQJXfkZ8GBftn7RtV1q56zgDmM7GF64IQukgZ4a31mkCGWitG9UKn/rBU2AmGfYann5jQQEan6J4mv7JlAYJ/magiSIkd9dHLi6+XOwTxAXOhhvfldUfS/3lqTTLDGMAmQJN2p2mAzwghgc8EjrUIgH1pRTWw4j7qjYK8HcyBNAAA=

Ipo Date

1994-03-03T00:00:00.000Z

Market Cap

1494856960

Next Dividend Date

-

Dividend Frequency

-

Dividend Rate

-

Dividend Yield

0

Sentiment

0.69168125

Sentiment Sources

16

Rating

4.4167

Target Price

20.4

Strong Buy

6

Buy

5

Hold

1

Sell

0

Strong Sell

0

Current Quarter

2025-09-30

Revenue

159395000

Cost Of Revenue

2522000

Gross Profit

156873000

Operating Expenses

127282000

Operating Income

29591000

Interest Expense

19661000

Pretax Income

12130000

Net Income

12899000

Eps

0.05866248266139118

Dividends Per Share

-

Shares Outstanding

210543224

Income Tax Expense

-769000

EBITDA

32126000

Operating Margin

18.56457228896766

Total Other Income Expense Net

-17461000

Cash

84078000

Short Term Investments

128794999

Receivables

91325000

Inventories

5232000

Total Current Assets

355684000

Property Plant Equipment

19236000

Total Assets

446424000

Payables

5567000

Short Term Debt

39469000

Long Term Debt

633473000

Total Liabilities

834313000

Equity

-387889000

Depreciation

335000

Change In Working Capital

-1370000

Cash From Operations

41111000

Capital Expenditures

1344000

Cash From Investing

13572000

Cash From Financing

-58301000

Net Change In Cash

-3868000

PE

-

PB

-4.291252007661986

ROE

-3.3254358850083396

ROA

2.8894055875132163

FCF

39767000

Fcf Percent

0.24948712318454155

Piotroski FScore

3

Health Score

52

Deep Value Investing Score

5

Defensive Investing Score

7

Dividend Investing Score

3

Economic Moat Investing Score

6.8

Garp Investing Score

5

Growth Investing Score

5

Momentum Investing Score

4

Net Net Investing Score

2

Quality Investing Score

3.5

Value Investing Score

3.5

Quarters > 0 > quarter

2025-09-30

Quarters > 0 > income Statement > revenue

159395000

Quarters > 0 > income Statement > cost Of Revenue

2522000

Quarters > 0 > income Statement > gross Profit

156873000

Quarters > 0 > income Statement > operating Expenses

127282000

Quarters > 0 > income Statement > operating Income

29591000

Quarters > 0 > income Statement > interest Expense

19661000

Quarters > 0 > income Statement > pretax Income

12130000

Quarters > 0 > income Statement > net Income

12899000

Quarters > 0 > income Statement > eps

0.05866248266139118

Quarters > 0 > income Statement > dividends Per Share

-

Quarters > 0 > income Statement > shares Outstanding

219885000

Quarters > 0 > income Statement > income Tax Expense

-769000

Quarters > 0 > income Statement > EBITDA

32126000

Quarters > 0 > income Statement > operating Margin

18.56457228896766

Quarters > 0 > income Statement > total Other Income Expense Net

-17461000

Quarters > 0 > balance Sheet > cash

84078000

Quarters > 0 > balance Sheet > short Term Investments

128794999

Quarters > 0 > balance Sheet > receivables

91325000

Quarters > 0 > balance Sheet > inventories

5232000

Quarters > 0 > balance Sheet > total Current Assets

355684000

Quarters > 0 > balance Sheet > property Plant Equipment

19236000

Quarters > 0 > balance Sheet > total Assets

446424000

Quarters > 0 > balance Sheet > payables

5567000

Quarters > 0 > balance Sheet > short Term Debt

39469000

Quarters > 0 > balance Sheet > long Term Debt

633473000

Quarters > 0 > balance Sheet > total Liabilities

834313000

Quarters > 0 > balance Sheet > equity

-387889000

Quarters > 0 > cash Flow > net Income

12899000

Quarters > 0 > cash Flow > depreciation

335000

Quarters > 0 > cash Flow > change In Working Capital

-1370000

Quarters > 0 > cash Flow > cash From Operations

41111000

Quarters > 0 > cash Flow > capital Expenditures

1344000

Quarters > 0 > cash Flow > cash From Investing

13572000

Quarters > 0 > cash Flow > cash From Financing

-58301000

Quarters > 0 > cash Flow > net Change In Cash

-3868000

Quarters > 0 > ratios > PE

0.05866248266139118

Quarters > 0 > ratios > PB

-4.291252007661986

Quarters > 0 > ratios > ROE

-3.3254358850083396

Quarters > 0 > ratios > ROA

2.8894055875132163

Quarters > 0 > ratios > FCF

39767000

Quarters > 0 > ratios > Piotroski FScore

3

Quarters > 0 > ratios > fcf Percent

0.24948712318454155

Quarters > 0 > health Score

52

Quarters > 1 > quarter

2025-06-30

Quarters > 1 > income Statement > revenue

163353000

Quarters > 1 > income Statement > cost Of Revenue

2798000

Quarters > 1 > income Statement > gross Profit

160555000

Quarters > 1 > income Statement > operating Expenses

130769000

Quarters > 1 > income Statement > operating Income

29786000

Quarters > 1 > income Statement > interest Expense

21582000

Quarters > 1 > income Statement > pretax Income

6486000

Quarters > 1 > income Statement > net Income

5085000

Quarters > 1 > income Statement > eps

0.02312561963926762

Quarters > 1 > income Statement > dividends Per Share

-

Quarters > 1 > income Statement > shares Outstanding

219886000

Quarters > 1 > income Statement > income Tax Expense

1401000

Quarters > 1 > income Statement > EBITDA

28397000

Quarters > 1 > income Statement > operating Margin

18.234130992390714

Quarters > 1 > income Statement > total Other Income Expense Net

-23300000

Quarters > 1 > balance Sheet > cash

88033000

Quarters > 1 > balance Sheet > short Term Investments

172005000

Quarters > 1 > balance Sheet > receivables

91177000

Quarters > 1 > balance Sheet > inventories

5044000

Quarters > 1 > balance Sheet > total Current Assets

398462000

Quarters > 1 > balance Sheet > property Plant Equipment

20003000

Quarters > 1 > balance Sheet > total Assets

457188000

Quarters > 1 > balance Sheet > payables

8589000

Quarters > 1 > balance Sheet > short Term Debt

2008000

Quarters > 1 > balance Sheet > long Term Debt

690636000

Quarters > 1 > balance Sheet > total Liabilities

878782000

Quarters > 1 > balance Sheet > equity

-421594000

Quarters > 1 > cash Flow > net Income

5085000

Quarters > 1 > cash Flow > depreciation

329000

Quarters > 1 > cash Flow > change In Working Capital

2377000

Quarters > 1 > cash Flow > cash From Operations

41302000

Quarters > 1 > cash Flow > capital Expenditures

179000

Quarters > 1 > cash Flow > cash From Investing

29127000

Quarters > 1 > cash Flow > cash From Financing

-73686000

Quarters > 1 > cash Flow > net Change In Cash

-16956000

Quarters > 1 > ratios > PE

0.02312561963926762

Quarters > 1 > ratios > PB

-3.948199025602831

Quarters > 1 > ratios > ROE

-1.2061367097254705

Quarters > 1 > ratios > ROA

1.112233916900706

Quarters > 1 > ratios > FCF

41123000

Quarters > 1 > ratios > Piotroski FScore

3

Quarters > 1 > ratios > fcf Percent

0.2517431574565511

Quarters > 1 > health Score

50

Quarters > 2 > quarter

2025-03-31

Quarters > 2 > income Statement > revenue

145534000

Quarters > 2 > income Statement > cost Of Revenue

4568000

Quarters > 2 > income Statement > gross Profit

140966000

Quarters > 2 > income Statement > operating Expenses

119739000

Quarters > 2 > income Statement > operating Income

21227000

Quarters > 2 > income Statement > interest Expense

23494000

Quarters > 2 > income Statement > pretax Income

758000

Quarters > 2 > income Statement > net Income

32000

Quarters > 2 > income Statement > eps

0.00014865674692582492

Quarters > 2 > income Statement > dividends Per Share

-

Quarters > 2 > income Statement > shares Outstanding

215261000

Quarters > 2 > income Statement > income Tax Expense

726000

Quarters > 2 > income Statement > EBITDA

24583000

Quarters > 2 > income Statement > operating Margin

14.585595118666427

Quarters > 2 > income Statement > total Other Income Expense Net

-20469000

Quarters > 2 > balance Sheet > cash

105481000

Quarters > 2 > balance Sheet > short Term Investments

189902000

Quarters > 2 > balance Sheet > receivables

93394000

Quarters > 2 > balance Sheet > inventories

6873000

Quarters > 2 > balance Sheet > total Current Assets

409977000

Quarters > 2 > balance Sheet > property Plant Equipment

19575000

Quarters > 2 > balance Sheet > total Assets

480047000

Quarters > 2 > balance Sheet > payables

10049000

Quarters > 2 > balance Sheet > short Term Debt

37171000

Quarters > 2 > balance Sheet > long Term Debt

782026000

Quarters > 2 > balance Sheet > total Liabilities

931974000

Quarters > 2 > balance Sheet > equity

-451927000

Quarters > 2 > cash Flow > net Income

32000

Quarters > 2 > cash Flow > depreciation

331000

Quarters > 2 > cash Flow > change In Working Capital

-62132000

Quarters > 2 > cash Flow > cash From Operations

-27517000

Quarters > 2 > cash Flow > capital Expenditures

143000

Quarters > 2 > cash Flow > cash From Investing

27095000

Quarters > 2 > cash Flow > cash From Financing

529000

Quarters > 2 > cash Flow > net Change In Cash

558000

Quarters > 2 > ratios > PE

0.00014865674692582492

Quarters > 2 > ratios > PB

-3.6057278498518563

Quarters > 2 > ratios > ROE

-0.0070807895965498855

Quarters > 2 > ratios > ROA

0.006666013952800455

Quarters > 2 > ratios > FCF

-27660000

Quarters > 2 > ratios > Piotroski FScore

1

Quarters > 2 > ratios > fcf Percent

-0.19005868044580648

Quarters > 2 > health Score

29

Quarters > 3 > quarter

2024-12-31

Quarters > 3 > income Statement > revenue

131534000

Quarters > 3 > income Statement > cost Of Revenue

6131000

Quarters > 3 > income Statement > gross Profit

125403000

Quarters > 3 > income Statement > operating Expenses

129911000

Quarters > 3 > income Statement > operating Income

-4508000

Quarters > 3 > income Statement > interest Expense

24449000

Quarters > 3 > income Statement > pretax Income

-25991000

Quarters > 3 > income Statement > net Income

-26795000

Quarters > 3 > income Statement > eps

-0.12920662934405755

Quarters > 3 > income Statement > dividends Per Share

-

Quarters > 3 > income Statement > shares Outstanding

207381000

Quarters > 3 > income Statement > income Tax Expense

804000

Quarters > 3 > income Statement > EBITDA

-1233000

Quarters > 3 > income Statement > operating Margin

-3.4272507488558093

Quarters > 3 > income Statement > total Other Income Expense Net

-21483000

Quarters > 3 > balance Sheet > cash

104923000

Quarters > 3 > balance Sheet > short Term Investments

216137000

Quarters > 3 > balance Sheet > receivables

79069000

Quarters > 3 > balance Sheet > inventories

8087000

Quarters > 3 > balance Sheet > total Current Assets

421968000

Quarters > 3 > balance Sheet > property Plant Equipment

19785000

Quarters > 3 > balance Sheet > total Assets

490420000

Quarters > 3 > balance Sheet > payables

11644000

Quarters > 3 > balance Sheet > short Term Debt

35448000

Quarters > 3 > balance Sheet > long Term Debt

795922000

Quarters > 3 > balance Sheet > total Liabilities

966354000

Quarters > 3 > balance Sheet > equity

-475934000

Quarters > 3 > cash Flow > net Income

-26795000

Quarters > 3 > cash Flow > depreciation

309000

Quarters > 3 > cash Flow > change In Working Capital

-11331000

Quarters > 3 > cash Flow > cash From Operations

-5213000

Quarters > 3 > cash Flow > capital Expenditures

675000

Quarters > 3 > cash Flow > cash From Investing

17797000

Quarters > 3 > cash Flow > cash From Financing

-4021000

Quarters > 3 > cash Flow > net Change In Cash

7259000

Quarters > 3 > ratios > PE

-0.12920662934405755

Quarters > 3 > ratios > PB

-3.298512335744032

Quarters > 3 > ratios > ROE

5.629982308471343

Quarters > 3 > ratios > ROA

-5.463684189062437

Quarters > 3 > ratios > FCF

-5888000

Quarters > 3 > ratios > Piotroski FScore

1

Quarters > 3 > ratios > fcf Percent

-0.044764091413626896

Quarters > 3 > health Score

20

Valuation > metrics > PE

0.05866248266139118

Valuation > metrics > PB

-4.291252007661986

Valuation > final Score

70

Valuation > verdict

99.4% Undervalued

Profitability > metrics > ROE

-3.3254358850083396

Profitability > metrics > ROA

3.626533664713622

Profitability > metrics > Net Margin

0.08092474669845352

Profitability > final Score

23

Profitability > verdict

Weak

Risk > metrics > Interest Coverage

1.5050607802248106

Risk > final Score

36

Risk > verdict

High

Liquidity > metrics > Current Ratio

7.897770672351008

Liquidity > metrics > Quick Ratio

7.781596944666489

Liquidity > final Score

100

Liquidity > verdict

Great

Prev Valuations > 0

70

Prev Valuations > 1

70

Prev Valuations > 2

50

Prev Profitabilities > 0

8

Prev Profitabilities > 1

0

Prev Profitabilities > 2

11

Prev Risks > 0

36

Prev Risks > 1

34

Prev Risks > 2

29

Prev Liquidities > 0

100

Prev Liquidities > 1

100

Prev Liquidities > 2

100

Updated At

2025-12-14T00:16:06.409Z